Cargando…
The ECMO PK Project: an incremental research approach to advance understanding of the pharmacokinetic alterations and improve patient outcomes during extracorporeal membrane oxygenation
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is a supportive therapy and its success depends on optimal drug therapy along with other supportive care. Emerging evidence suggests significant interactions between the drug and the device resulting in altered pharmacokinetics (PK) of vital dru...
Autores principales: | Shekar, Kiran, Roberts, Jason A, Smith, Maree T, Fung, Yoke L, Fraser, John F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643838/ https://www.ncbi.nlm.nih.gov/pubmed/23517311 http://dx.doi.org/10.1186/1471-2253-13-7 |
Ejemplares similares
-
ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO
por: Shekar, Kiran, et al.
Publicado: (2012) -
Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models
por: Shekar, Kiran, et al.
Publicado: (2015) -
972. Imipenem-Cilastatin-Relebactam (I/R) Pharmacokinetics (PK) in Critically Ill Patients Supported on Extracorporeal Membrane Oxygenation (ECMO)
por: Fratoni, Andrew J, et al.
Publicado: (2023) -
Population Pharmacokinetics and Dosing Simulations of Ceftriaxone in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (An ASAP ECMO Study)
por: Cheng, Vesa, et al.
Publicado: (2022) -
Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation
por: Shekar, Kiran, et al.
Publicado: (2012)